Haoxi Health Technology Limited Class A Ordinary Shares (HAO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haoxi Health Technology Limited Class A Ordinary Shares (HAO) has a cash flow conversion efficiency ratio of -0.142x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.27 Million) by net assets ($15.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Haoxi Health Technology Limited Class A for the company's overall valuation and market capitalisation.
Haoxi Health Technology Limited Class A Ordinary Shares - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Haoxi Health Technology Limited Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Haoxi Health Technology Limited Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haoxi Health Technology Limited Class A Ordinary Shares ranked by their cash flow conversion efficiency. Explore Haoxi Health Technology Limited Class A cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Solar Alliance Energy Inc
V:SOLR
|
0.001x |
|
MACDONALD MNS EXPL. A
F:3M7
|
N/A |
|
Edible Garden AG Inc
NASDAQ:EDBL
|
0.028x |
|
Miramar Resources Ltd
AU:M2R
|
-0.007x |
|
Star Pacific Tbk
JK:LPLI
|
0.000x |
|
Vp plc
LSE:VP
|
0.245x |
|
Vision Lithium Inc
V:VLI
|
-0.007x |
|
Human Xtensions Ltd
TA:HUMX
|
-0.626x |
Annual Cash Flow Conversion Efficiency for Haoxi Health Technology Limited Class A Ordinary Shares (2020–2025)
The table below shows the annual cash flow conversion efficiency of Haoxi Health Technology Limited Class A Ordinary Shares from 2020 to 2025. View HAO stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $17.38 Million | $-3.36 Million | -0.193x | -191.39% |
| 2024-12-31 | $11.27 Million | $-747.58K | -0.066x | 0.00% |
| 2023-12-31 | $11.27 Million | $-747.58K | -0.066x | +88.09% |
| 2022-12-31 | $1.57 Million | $-872.13K | -0.557x | -220.82% |
| 2021-12-31 | $-1.47 Million | $-675.36K | 0.461x | +133.59% |
| 2020-12-31 | $-1.93 Million | $2.65 Million | -1.372x | -- |
About Haoxi Health Technology Limited Class A Ordinary Shares
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various … Read more